ContextMost antidiabetic agents target only 1 of several underlying causes of diabetes. The
complementary actions of the antidiabetic agents metformin hydrochloride and rosiglitazone …

Background Combination therapy is logical for patients with non-insulin-dependent (type II)
diabetes mellitus, because they often have poor responses to single-drug therapy. We …

Aim: This double‐blind study evaluated the efficacy and safety of metformin‐glibenclamide
tablets vs. metformin plus rosiglitazone therapy in patients with type 2 diabetes inadequately …

BACKGROUND:: Management of type 2 diabetes mellituBackground: 026 (DM) that involves
uptitration of monotherapy to the maximum dose has been associated with delays in …

Background Type 2 diabetes is a growing problem in Mexico. The present study was
undertaken to evaluate the efficacy and safety of rosiglitazone 2 mg or 4 mg twice daily (bd) …

Aim: This study assessed the efficacy and safety of rosiglitazone and metformin (RSG/MET)
fixed‐dose combination (AVANDAMET) as initial therapy in patients with uncontrolled type 2 …

Abstract Background This 52‐week, randomized, double‐blind study compared the efficacy
and safety of metformin plus pioglitazone with the established combination of metformin plus …

PURPOSE: To study the efficacy and safety of various dosages of metformin as compared
with placebo in patients with type II diabetes mellitus. PATIENTS AND METHODS: A 14 …

Aims To compare glucose control over 18 months between rosiglitazone oral combination
therapy and combination metformin and sulphonylurea in people with Type 2 diabetes …

PURPOSE: To assess the efficacy and safety of adding rosiglitazone to an established
regimen of glyburide/metformin in patients with type 2 diabetes who had not achieved …